Phase 2 Diabetic Kidney Disease (DKD) Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Regeneron Pharmaceuticals270 enrolled47 locationsNCT07271186
Recruiting
Phase 2
Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Chinese PLA General Hospital120 enrolled6 locationsNCT06969807
Recruiting
Phase 2
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Diabetic Kidney Disease (DKD)
Aptabio Therapeutics, Inc.186 enrolled20 locationsNCT06962098
Completed
Phase 2
Study to assess the safety and effectiveness of propagermanium as add-on therapy in Diabetic Kidney Disease (DKD) patients who are already taking Irbesartan
Diabetic Kidney Disease (DKD)
Dimerix Ltd40 enrolled14 locationsACTRN12618000982213